FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:503-504 February 17, 1994 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kassirer, J. P. Related Article by Thompson, D. F.

To the Editor: I take issue with the statement by Kassirer and Angell (Aug. 19 issue)¹ that "financial conflicts of interest are a matter of choice." This implies that biomedical research worthy of publication takes place only in academic institutions and ignores the fact that important research is not only financed, but also performed, by commercial companies.

Stringent policies on the authorship of review articles disenfranchise scientists in industry and may paradoxically lead to increased secrecy, because they reinforce the view that publications by such employees lack credibility. Such policies may also exclude the opinions of acknowledged experts: Paul Ehrlich . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.